|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: SI TECHNOLOGIES INC, 10KSB40, EX-23.1, 2000-10-27 |
Next: MOLECULAR BIOSYSTEMS INC, 8-K, 2000-10-27 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 12-MOS
<FISCAL-YEAR-END> JUL-31-2000
<PERIOD-START> AUG-01-1999
<PERIOD-END> JUL-31-2000
<CASH> 112,286
<SECURITIES> 0
<RECEIVABLES> 7,378,024
<ALLOWANCES> 220,864
<INVENTORY> 8,866,766
<CURRENT-ASSETS> 17,969,033
<PP&E> 10,459,037
<DEPRECIATION> 4,810,074
<TOTAL-ASSETS> 33,223,071
<CURRENT-LIABILITIES> 9,539,924
<BONDS> 0
0
0
<COMMON> 3,547,123
<OTHER-SE> 11,692,195
<TOTAL-LIABILITY-AND-EQUITY> 33,223,071
<SALES> 41,329,345
<TOTAL-REVENUES> 41,329,345
<CGS> 26,725,874
<TOTAL-COSTS> 26,725,874
<OTHER-EXPENSES> 12,104,266
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> (1,860,131)
<INCOME-PRETAX> 694,798
<INCOME-TAX> (343,608)
<INCOME-CONTINUING> 0
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 351,190
<EPS-BASIC> .10
<EPS-DILUTED> .09
</TABLE>
|
|